Exelon (NASDAQ:EXC - Get Free Report) will likely be posting its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect the company to post earnings of $0.78 per share and revenue of $6.73 billion for the quarter. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. Individuals may visit the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Friday, October 30, 2026 at 10:00 AM ET.
Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.01). Exelon had a net margin of 10.99% and a return on equity of 9.81%. The business had revenue of $5.97 billion during the quarter, compared to the consensus estimate of $5.44 billion. During the same period last year, the company earned $0.39 EPS. The business's revenue was up 10.0% compared to the same quarter last year. On average, analysts expect Exelon to post $2.86 EPS for the current fiscal year and $3.05 EPS for the next fiscal year.
Exelon Stock Performance
EXC stock opened at $44.85 on Friday. The company has a quick ratio of 0.99, a current ratio of 1.09 and a debt-to-equity ratio of 1.71. The business's fifty day simple moving average is $42.86 and its two-hundred day simple moving average is $45.04. Exelon has a twelve month low of $39.73 and a twelve month high of $50.65. The firm has a market cap of $46.30 billion, a price-to-earnings ratio of 16.43, a PEG ratio of 2.35 and a beta of 0.30.
Exelon Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Friday, September 4th were paid a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend was Friday, September 4th. Exelon's payout ratio is currently 61.54%.
Analysts Set New Price Targets
EXC has been the topic of a number of research analyst reports. Weiss Ratings restated a "buy (b-)" rating on shares of Exelon in a report on Tuesday, October 6th. Truist Financial reduced their price target on shares of Exelon from $48.00 to $46.00 and set a "hold" rating on the stock in a research note on Friday, October 16th. Argus decreased their price objective on shares of Exelon from $52.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, September 22nd. Barclays lowered their price objective on shares of Exelon from $49.00 to $44.00 and set an "equal weight" rating for the company in a research report on Monday. Finally, Morgan Stanley lowered their price objective on shares of Exelon from $50.00 to $49.00 and set an "equal weight" rating for the company in a research report on Wednesday. Four investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $48.06.
Get Our Latest Stock Report on Exelon
About Exelon
(
Get Free Report)
Exelon Corporation NASDAQ: EXC is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.
Exelon's utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.